Findings indicate that non-Hispanic Black patients with colon cancer treated at Commission on Cancer (CoC)-accredited hospitals received significantly more guideline-concordant care than those treated at non-accredited facilities. Specifically, the odds of undergoing necessary lymphadenectomy and chemotherapy were higher (adjusted odds ratios of 1.89 and 2.31, respectively). Moreover, patients at accredited hospitals demonstrated lower cancer-specific mortality, with adjusted hazard ratios of 0.87 for surgical patients and 0.75 for chemotherapy-eligible patients.
Journal Article by Chan K, Palis BE (…) Ko CY et 4 al. in JAMA Netw Open